INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 1 filers reported holding INTERSECT ENT INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,117,000 | +2.6% | 75,569 | 0.0% | 0.05% | +4.3% |
| Q4 2021 | $2,064,000 | -0.7% | 75,569 | -1.1% | 0.05% | +4.4% |
| Q3 2021 | $2,078,000 | +202.5% | 76,401 | +90.2% | 0.04% | +200.0% |
| Q2 2021 | $687,000 | -15.1% | 40,174 | +3.7% | 0.02% | -16.7% |
| Q1 2021 | $809,000 | -9.9% | 38,735 | -1.2% | 0.02% | +5.9% |
| Q4 2020 | $898,000 | +36.1% | 39,206 | -3.1% | 0.02% | -5.6% |
| Q3 2020 | $660,000 | +8.0% | 40,450 | -10.3% | 0.02% | 0.0% |
| Q2 2020 | $611,000 | +6.8% | 45,104 | -6.5% | 0.02% | -18.2% |
| Q1 2020 | $572,000 | -23.4% | 48,245 | +60.8% | 0.02% | +83.3% |
| Q4 2019 | $747,000 | +75.8% | 30,000 | +20.0% | 0.01% | +33.3% |
| Q3 2019 | $425,000 | +86.4% | 25,000 | +150.0% | 0.01% | +50.0% |
| Q2 2019 | $228,000 | -29.2% | 10,000 | 0.0% | 0.01% | -25.0% |
| Q1 2019 | $322,000 | +14.2% | 10,000 | 0.0% | 0.01% | -33.3% |
| Q4 2018 | $282,000 | -56.9% | 10,000 | -42.9% | 0.01% | -25.0% |
| Q2 2018 | $655,000 | +66.7% | 17,500 | +75.0% | 0.02% | +33.3% |
| Q1 2018 | $393,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|